Vastra Gotaland Region
Clinical trials sponsored by Vastra Gotaland Region, explained in plain language.
-
Could one pill be enough after a heart attack?
Disease control CompletedThis study tested if using just one blood-thinning drug (ticagrelor) is safe for patients after they get a stent for a heart attack. Usually, patients take two drugs. The goal was to see if using only one could lower the risk of bleeding while still preventing future heart proble…
Phase: PHASE2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists test direct liver attack on advanced melanoma
Disease control CompletedThis early-stage study tested the safety of a new treatment for melanoma that has spread to the liver. Doctors took a patient's own tumor-fighting immune cells, grew more of them in a lab, and then infused them directly into the liver's blood supply. The main goal was to see if t…
Phase: PHASE1 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New knee test device put to the test
Diagnosis CompletedThis study aimed to see if a newer device (GNRB) is a reliable tool for measuring knee looseness in patients with ACL injuries. It compared the GNRB to an older, commonly used device (KT1000) in 17 patients before and after their ACL reconstruction surgery. The main goal was to c…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Diagnosis
Last updated Mar 24, 2026 12:03 UTC
-
Massive study digs into osteoarthritis data to predict who needs surgery
Knowledge-focused CompletedThis study analyzed health records from over 75,000 Swedish patients with hip or knee osteoarthritis to learn more about their health and social factors. Researchers compared these patients to the general population to understand who does well with standard treatment (education a…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists track COVID-19 immunity in vulnerable CF patients
Knowledge-focused CompletedThis study aimed to understand how people with cystic fibrosis (CF) respond to COVID-19. Researchers followed 113 children and adults with CF in Europe for two years, checking their blood for COVID-19 antibodies at regular clinic visits. The goal was to see how many got infected,…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC